Skip to content

Establishment of epilepsy clinical research cohort and individualized treatment plan

Establishment of epilepsy clinical research cohort and individualized treatment plan

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052625
Enrollment
Unknown
Registered
2021-11-02
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epilepsy

Interventions

MRI positive epilepsy group:none
MRI negative epilepsy group:none
Control group without epilepsy:none

Sponsors

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients in the MRI epilepsy positive group and MRI epilepsy negative group are patients who meet the diagnosis of epilepsy in symptomatology and EEG examination and are admitted to the hospital for evaluation and treatment; the seizure-free group is the control group without seizures, such as brain tumors, patients with traumatic brain injury; 2. Aged >= 3 years; 3. Sign the informed consent form voluntarily, with good compliance and able to cooperate with follow-up; 4. Research subjects (or their legal representatives) have signed an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with serious diseases of the heart, liver, and kidney, and female patients during pregnancy and lactation; 2. Patients with poor compliance, irregular medication, and lost to follow-up after treatment; 3. Patients who require withdrawal from clinical research; 4. Participated in other clinical studies 2 months before the start of the study.

Design outcomes

Primary

MeasureTime frame
Seizure control;Electroencephalogram database typing;Image database classification;Molecular mechanism exploration;

Secondary

MeasureTime frame
Histopathological typing;Molecular biomarkers;Omics change research;Brain-gut-microbe axis;Gene sequencing research;

Countries

China

Contacts

Public ContactFei Xiaorui

The First Affiliated Hospital of University of science and technology of China (Anhui Provincial Hospital)

neurofei@163.com+86 13865934421

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026